Ordinance
on Licensing in the Medicinal Products Sector
(Medicinal Products Licensing Ordinance, MPLO)

¹ This Or­din­ance reg­u­lates:

a.

the man­u­fac­ture of medi­cin­al products;

b.

whole­sale trad­ing in medi­cin­al products;

c.

the im­port, ex­port and trans­it trade in medi­cin­al products;

d.

trad­ing in medi­cin­al products in for­eign coun­tries from Switzer­land;

e.

the ex­tract­ing of blood for trans­fu­sions or for the man­u­fac­ture of medi­cin­al products to­geth­er with oth­er es­sen­tial ele­ments of trans­fu­sion safety in hand­ling blood and labile blood products;

f.

broker­age or agency activ­it­ies in con­nec­tion with medi­cin­al products;

g.

tem­por­ary li­cences to use medi­cin­al products in ac­cord­ance with Art­icle 9b para­graph 1 TPA.

² With the ex­cep­tion of Art­icles 27, 28 and 47, this Or­din­ance ap­plies by ana­logy to the hand­ling of trans­plant products as de­scribed in Art­icle 2 para­graph 1 let­ter c of the Trans­plant­a­tion Or­din­ance of 16 March 2007².

³ Art­icles 29–38 do not ap­ply to trans­plant products de­scribed in Art­icle 2 para­graph 1 let­ter c num­ber 2 of the Trans­plant­a­tion Or­din­ance of 16 March 2007.